Alan Morrison is Vice President of Regulatory Affairs international at MSD and has served as the Chair of EFPIA’s Regulatory Strategy Committee since 2018. In this role, Alan leads the MSD international regulatory organisation across Europe, Middle East and Africa, Canada, Latin America and Asia Pacific, plus responsibilities for China and Japan – one of the industry’s largest global geographic footprints. As well as being part of the global regulatory leadership team, Alan is also a member of the international cross-divisional leadership team defining the overall strategy and direction of the ex-US business and organisation.

Alan was previously Vice President, International Regulatory Affairs and Safety at Amgen. In that role, Alan was responsible for regulatory and safety teams across Europe, Latin America, Middle East and Africa, Canada, Asia Pacific, China and Japan. In addition, he led global labeling, regulatory writing, publishing and submissions capabilities, supporting all Amgen operating regions including United States.

Previously, Alan held leadership positions in global regulatory affairs at several multinational companies, including Celltech, Baxter, BMS and Johnson & Johnson. Alan is active in professional qualification and membership societies, including PhRMA, TOPRA and EFPIA. He holds a B.Sc. in Biology and Physiology from the University of Stirling.

Alan acts on a number of trade association committees related to biotechnology / biopharmaceuticals. Currently, Alan is Chair of the EFPIA Regulatory Strategy Committee and Chair of the EFPIA Brexit Taskforce. Alan was also Chair of the UK BioIndustry Association (BIA) Regulatory Affairs Committee from 2009 - 2018.